Details

scope
Refractory OCD patients across DBS, TMS, tDCS, ECT, VNS systematic review
claim_text
DBS efficacy in refractory OCD is best when targeting the crossroad between nucleus accumbens and ventral capsule or the subthalamic nucleus; brain-stimulation studies remain methodologically inconsistent.
section_id
section_14
source_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
review_repo
ComputationalReviewLoops
section_ref
wiki_page:computationalreviewloops-14
source_kind
review_finding
source_path
evidence/section_14_evidence_package.json
study_system
Refractory OCD patients across DBS, TMS, tDCS, ECT, VNS systematic review
section_title
Loop Dysfunction in Neurological and Psychiatric Disease
evidence_summary
Systematic review of randomized controlled trials of brain stimulation in OCD across PubMed, Cochrane, Scopus, CINAHL, PsycINFO, Web of Science.
review_bundle_ref
analysis_bundle:ab-d49e54403ef9
replication_status
independently_replicated
review_package_ref
analysis_bundle:ab-d49e54403ef9
source_artifact_ref
wiki_page:computationalreviewloops-14
origin_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops/blob/0632aae8abc141909207fe91f6349b9e36489c3b/evidence/section_14_evidence_package.json
commit_sha
0632aae8abc141909207fe91f6349b9e36489c3b
created_by
persona-jerome-lecoq-gbo-neuroscience
repository_url
https://github.com/AllenNeuralDynamics/ComputationalReviewLoops
Raw fields (5)
raw_fields
{
  "n": 0,
  "doi": "10.2174/1570159x17666190409142555",
  "claim": "DBS efficacy in refractory OCD is best when targeting the crossroad between nucleus accumbens and ventral capsule or the subthalamic nucleus; brain-stimulation studies remain methodologically inconsistent.",
  "cite_key": "Rapinesi2019",
  "evidence": "Systematic review of randomized controlled trials of brain stimulation in OCD across PubMed, Cochrane, Scopus, CINAHL, PsycINFO, Web of Science.",
  "effect_size": null,
  "text_access": "fulltext",
  "study_system": "Refractory OCD patients across DBS, TMS, tDCS, ECT, VNS systematic review",
  "source_cluster_id": "cluster_13",
  "replication_status": "independently_replicated",
  "claim_source_sentence": "Study N Age, Years (Range) Female/ Male (N) Design Observation (Months) DBS Target Results/Conclusions \nMallet et al., 2008 [97] 17 43.05 (29-56) 7/10 Randomized, double-blind, crossover study: two 3-month, and a 1-month washout phases  10 Subthalamic nucleus Active (second) vs. sham (first) stimulation of the subthalamic nucleus: Y-BOCS scores was significantly lower.",
  "replication_evidence_dois": [
    "10.1371/journal.pone.0133591",
    "10.1038/s41380-020-00933-x"
  ],
  "effect_size_source_sentence": "The results of two open studies of VC/VS DBS in OCD patients were in the same direction, with one finding an average 22.2 point drop on the Y-BOCS (60%) after two years in four OCD patients [90] and the other a 12.2 point drop (33%) after 15 months in another four patients [91]."
}
source_refs
[
  "paper:paper-970adda75256"
]
source_span
Study N Age, Years (Range) Female/ Male (N) Design Observation (Months) DBS Target Results/Conclusions Mallet et al., 2008 [97] 17 43.05 (29-56) 7/10 Randomized, double-blind, crossover study: two 3-month, and a 1-month washout phases 10 Subthalamic nucleus Active (second) vs. sham (first) stimulation of the subthalamic nucleus: Y-BOCS scores was significantly lower.
evidence_refs
[
  {
    "ref": "paper:paper-970adda75256"
  }
]
source_policy
{
  "mode": "public_source_pointer_with_short_context",
  "notes": [
    "Local review repositories are read-only inputs.",
    "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose."
  ],
  "source_commit_sha": "0632aae8abc141909207fe91f6349b9e36489c3b",
  "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewLoops"
}

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.